Pesquisas alternativas:
computers » computer (Expandir a Pesquisa)
ngoc » ngo (Expandir a Pesquisa)
nabl » natl (Expandir a Pesquisa), abl (Expandir a Pesquisa), nail (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 217 para a pesquisa '(( j large computers can ngoc ) OR ((( _ nabl compared cases now ) OR ( _ nab compared a non ))))', tempo de pesquisa: 0.40seg Refinar resultados
Effect of bubble-bubble interaction in Cu−Al2O3/H2O hybrid nanofluids during multibubble growth process
Accelerating functional MRI using fixed‐rank approximations and radial‐cartesian sampling

Generalized Diffusion Spectrum Magnetic Resonance Imaging (GDSI) for Model-free Reconstruction of the Ensemble Average Propagator
Therapeutic interventions for osteoarthritis of the wrist: a systematic review and meta-analysis

Standards for the measurement of birth weight, length and head circumference at term in neonates of European, Chinese and South Asian ancestry
1520. Determining the Management of Children with Acute UTI/Pyelonephritis Who Do Not Fit Current Management Recommendations

Suitability of bovine portion condemnations at provincially-inspected abattoirs in Ontario Canada for food animal syndromic surveillance
Suitability of bovine portion condemnations at provincially-inspected abattoirs in Ontario Canada for food animal syndromic surveillance

Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer
Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer
Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study

Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review
Corrigendum to Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa